Analytical Data
-
Gene name
RGC32
- Application
-
Alternative Names
RGC32；C13orf15；RGC32；Regulator of cell cycle RGCC
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H4X1
-
Expression Region
1-137aa
-
AA Sequence
MKPPAAQGSP AAAAAAAPAL DSAAAEDLSD ALCEFDAVLA DFASPFHERH FHYEEHLERM KRRSSASVSD SSGFSDSESA DSLYRNSFSF SDEKLNSPTD STPALLSATV TPQKAKLGDT KELEAFIADL DKTLASM
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RGC32, or Regulator of G-protein signaling 32, is a protein that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its expression is often associated with specific tissues and has been implicated in several physiological and pathological conditions, particularly in cancerous tissues. The interest in RGC32 research stems from its regulatory effects on G-protein signaling pathways, which are essential for transmitting extracellular signals to the cell's interior. Abnormalities in these pathways can lead to unchecked cell growth and tumor development. Recent studies have indicated that RGC32 may act as a tumor suppressor in certain contexts, making it a potential target for therapeutic interventions. Moreover, the ability to produce recombinant RGC32 protein allows for detailed characterizations of its functional properties and interactions with other signaling molecules. Such research could provide insights into its mechanisms of action and its potential implications in cancer biology and treatment. Understanding the role of RGC32 in cellular signaling may therefore reveal novel therapeutic strategies to combat cancers where this pathway is dysregulated.
